Name | Description | Size | Catalog # | |
---|---|---|---|---|
NNC 55-0396 dihydrochloride | NNC 55-0396 displays IC50 values of 6.8 and >100 µM for inhibitio… | 25 mg | N-205 | More Info |
NNC 55-0396 dihydrochloride | NNC 55-0396 displays IC50 values of 6.8 and >100 µM for inhibitio… | 5 mg | N-205 | More Info |
NNC 55-0396 dihydrochloride | NNC 55-0396 displays IC50 values of 6.8 and >100 µM for inhibitio… | 50 mg | N-205 | More Info |
NNC 55-0396 dihydrochloride hydrate | NNC 55-0396 displays IC50 values of 6.8 and >100 µM for inhibitio… | 10 mg | N-206 | More Info |
NNC 55-0396 dihydrochloride hydrate | NNC 55-0396 displays IC50 values of 6.8 and >100 µM for inhibitio… | 25 mg | N-206 | More Info |
NNC 55-0396 dihydrochloride hydrate | NNC 55-0396 displays IC50 values of 6.8 and >100 µM for inhibitio… | 5 mg | N-206 | More Info |
5-(N,N-Dimethyl)amiloride hydrochloride | 5-(N,N-Dimethyl)amiloride hydrochloride blocks TRPA1 channels with an IC50… | 10 mg | D-165 | More Info |
5-(N,N-Dimethyl)amiloride hydrochloride | 5-(N,N-Dimethyl)amiloride hydrochloride blocks TRPA1 channels with an IC50… | 100 mg | D-165 | More Info |
5-(N,N-Dimethyl)amiloride hydrochloride | 5-(N,N-Dimethyl)amiloride hydrochloride blocks TRPA1 channels with an IC50… | 25 mg | D-165 | More Info |
5-(N,N-Dimethyl)amiloride hydrochloride | 5-(N,N-Dimethyl)amiloride hydrochloride blocks TRPA1 channels with an IC50… | 5 mg | D-165 | More Info |
5-(N,N-Dimethyl)amiloride hydrochloride | 5-(N,N-Dimethyl)amiloride hydrochloride blocks TRPA1 channels with an IC50… | 50 mg | D-165 | More Info |
Nonivamide | Nonivamide is a TRPV1 activator1. Synthetic. Purity >98%. MW: 293.4 | 1 g | N-220 | More Info |
Nonivamide | Nonivamide is a TRPV1 activator1. Synthetic. Purity >98%. MW: 293.4 | 250 mg | N-220 | More Info |
Nonivamide | Nonivamide is a TRPV1 activator1. Synthetic. Purity >98%. MW: 293.4 | 500 mg | N-220 | More Info |
1-Norokadaone | 1-Norokadaone is an inactive analogue of okadaic acid (a PP1 and PP2A inhi… | 5 µg | N-750 | More Info |
Novokinin | An Angiotensin II Receptor Agonist1. Synthetic peptide. Purity ≥98% (HP… | 1 mg | SPA-125 | More Info |
Novokinin | An Angiotensin II Receptor Agonist1. Synthetic peptide. Purity ≥98% (HP… | 10 mg | SPA-125 | More Info |
Novokinin | An Angiotensin II Receptor Agonist1. Synthetic peptide. Purity ≥98% (HP… | 25 mg | SPA-125 | More Info |
Novokinin | An Angiotensin II Receptor Agonist1. Synthetic peptide. Purity ≥98% (HP… | 5 mg | SPA-125 | More Info |
Novokinin | An Angiotensin II Receptor Agonist1. Synthetic peptide. Purity ≥98% (HP… | 50 mg | SPA-125 | More Info |
Noxiustoxin | Noxiustoxin inhibits KV1.2 and KV1.3 K+ channels1. Synthetic peptide. Puri… | 0.1 mg | STN-340 | More Info |
Noxiustoxin | Noxiustoxin inhibits KV1.2 and KV1.3 K+ channels1. Synthetic peptide. Puri… | 10 µg | STN-340 | More Info |
Noxiustoxin | Noxiustoxin inhibits KV1.2 and KV1.3 K+ channels1. Synthetic peptide. Puri… | 5 µg | STN-340 | More Info |
Noxiustoxin | Noxiustoxin inhibits KV1.2 and KV1.3 K+ channels1. Synthetic peptide. Puri… | 5 x 10 µg | STN-340 | More Info |
Noxiustoxin | Noxiustoxin inhibits KV1.2 and KV1.3 K+ channels1. Synthetic peptide. Puri… | 5 x 5 µg | STN-340 | More Info |
NPS 2390 | NPS 2390, a quinoxaline derivative, is a potent and selective non-competit… | 10 mg | N-340 | More Info |
NPS 2390 | NPS 2390, a quinoxaline derivative, is a potent and selective non-competit… | 25 mg | N-340 | More Info |
NPS 2390 | NPS 2390, a quinoxaline derivative, is a potent and selective non-competit… | 5 mg | N-340 | More Info |
NPS 2390 | NPS 2390, a quinoxaline derivative, is a potent and selective non-competit… | 50 mg | N-340 | More Info |
NS-11021 | NS-11021 is a potent KCa1.1 channel agonist, enhancing KCa1.1 currents wit… | 10 mg | N-335 | More Info |
NS-11021 | NS-11021 is a potent KCa1.1 channel agonist, enhancing KCa1.1 currents wit… | 25 mg | N-335 | More Info |
NS-11021 | NS-11021 is a potent KCa1.1 channel agonist, enhancing KCa1.1 currents wit… | 5 mg | N-335 | More Info |
NS-11021 | NS-11021 is a potent KCa1.1 channel agonist, enhancing KCa1.1 currents wit… | 50 mg | N-335 | More Info |
NS-1619 | NS-1619 is a potent and selective KCa1.1 (BK, slo, Large conductance Ca2+-… | 10 mg | N-105 | More Info |
NS-1619 | NS-1619 is a potent and selective KCa1.1 (BK, slo, Large conductance Ca2+-… | 25 mg | N-105 | More Info |
NS-1619 | NS-1619 is a potent and selective KCa1.1 (BK, slo, Large conductance Ca2+-… | 5 mg | N-105 | More Info |
NS-1643 | NS-1643 is a potent and selective KV11.1 (hERG, ERG1, erg1) channel modula… | 10 mg | N-115 | More Info |
NS-1643 | NS-1643 is a potent and selective KV11.1 (hERG, ERG1, erg1) channel modula… | 50 mg | N-115 | More Info |
NS19504 | NS19504 is a KCa1.1 channel opener1. Synthetic. Purity >99%. MW: 269.2 | 10 mg | N-235 | More Info |
NS19504 | NS19504 is a KCa1.1 channel opener1. Synthetic. Purity >99%. MW: 269.2 | 25 mg | N-235 | More Info |
NS19504 | NS19504 is a KCa1.1 channel opener1. Synthetic. Purity >99%. MW: 269.2 | 5 mg | N-235 | More Info |
NS19504 | NS19504 is a KCa1.1 channel opener1. Synthetic. Purity >99%. MW: 269.2 | 50 mg | N-235 | More Info |
NS-309 | NS-309 is a positive modulator of small- and intermediate- conductance Ca2… | 10 mg | N-180 | More Info |
NS-309 | NS-309 is a positive modulator of small- and intermediate- conductance Ca2… | 25 mg | N-180 | More Info |
NS-309 | NS-309 is a positive modulator of small- and intermediate- conductance Ca2… | 5 mg | N-180 | More Info |
NS-309 | NS-309 is a positive modulator of small- and intermediate- conductance Ca2… | 50 mg | N-180 | More Info |
NS-3623 | NS-3623 is an opener of KV11.1 channels with an EC50 of 10.5 µM1. Sy… | 10 mg | N-190 | More Info |
NS-3623 | NS-3623 is an opener of KV11.1 channels with an EC50 of 10.5 µM1. Sy… | 25 mg | N-190 | More Info |
NS-3623 | NS-3623 is an opener of KV11.1 channels with an EC50 of 10.5 µM1. Sy… | 5 mg | N-190 | More Info |
NS-3623 | NS-3623 is an opener of KV11.1 channels with an EC50 of 10.5 µM1. Sy… | 50 mg | N-190 | More Info |
NS-4591 | NS-4591 is a potent SK4 channel activator; 30 nM doubled KCa3.1 currents i… | 10 mg | N-325 | More Info |
NS-4591 | NS-4591 is a potent SK4 channel activator; 30 nM doubled KCa3.1 currents i… | 25 mg | N-325 | More Info |
NS-4591 | NS-4591 is a potent SK4 channel activator; 30 nM doubled KCa3.1 currents i… | 5 mg | N-325 | More Info |
NS-4591 | NS-4591 is a potent SK4 channel activator; 30 nM doubled KCa3.1 currents i… | 50 mg | N-325 | More Info |
NS-6180 | NS-6180 blocks SK4 channels with IC50 of 9, 14 and 15 nM for rat, human an… | 10 mg | N-230 | More Info |
NS-6180 | NS-6180 blocks SK4 channels with IC50 of 9, 14 and 15 nM for rat, human an… | 25 mg | N-230 | More Info |
NS-6180 | NS-6180 blocks SK4 channels with IC50 of 9, 14 and 15 nM for rat, human an… | 5 mg | N-230 | More Info |
NS-6180 | NS-6180 blocks SK4 channels with IC50 of 9, 14 and 15 nM for rat, human an… | 50 mg | N-230 | More Info |
NS8593 | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 10 mg | N-196 | More Info |
NS8593 | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 25 mg | N-196 | More Info |
NS8593 | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 5 mg | N-196 | More Info |
NS8593 | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 50 mg | N-196 | More Info |
NS8593 hydrochloride | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 10 mg | N-195 | More Info |
NS8593 hydrochloride | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 25 mg | N-195 | More Info |
NS8593 hydrochloride | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 5 mg | N-195 | More Info |
NS8593 hydrochloride | NS8593 is KCa2 (SK) channel blocker, with no activity towards KCa3.1 chann… | 50 mg | N-195 | More Info |
Ochratoxin A | Ochratoxin A causes an increase in ATP-driven Ca2+ pump activity in the ER… | 0.5 mg | O-400 | More Info |
Ochratoxin A | Ochratoxin A causes an increase in ATP-driven Ca2+ pump activity in the ER… | 1 mg | O-400 | More Info |
Ochratoxin A | Ochratoxin A causes an increase in ATP-driven Ca2+ pump activity in the ER… | 5 x 1 mg | O-400 | More Info |
Okadaic Acid (ammonium salt) | Okadaic Acid is a potent inhibitor of PP1 and PP2A1. At higher concentrati… | 0.1 mg | O-800 | More Info |
Okadaic Acid (ammonium salt) | Okadaic Acid is a potent inhibitor of PP1 and PP2A1. At higher concentrati… | 10 µg | O-800 | More Info |
Okadaic Acid (ammonium salt) | Okadaic Acid is a potent inhibitor of PP1 and PP2A1. At higher concentrati… | 25 µg | O-800 | More Info |
Okadaic Acid (ammonium salt) | Okadaic Acid is a potent inhibitor of PP1 and PP2A1. At higher concentrati… | 5 x 25 µg | O-800 | More Info |
Okadaic Acid (sodium salt) | Okadaic Acid is a potent inhibitor of PP1 and PP2A1. At higher concentrati… | 25 µg | O-900 | More Info |
Okadaic Acid (sodium salt) | Okadaic Acid is a potent inhibitor of PP1 and PP2A1. At higher concentrati… | 5 x 25 µg | O-900 | More Info |
U.S.A. OFFICE
Toll free phone: 1800-618-1644 / 1800-791-3904
Toll free fax: 1888-454-7276 / 1800-791-3912